Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study of CM-101 in Patients With Non-Alcoholic Steatohepatitis (NASH)

NCT05824156 is registered in ClinicalTrials.gov with ChemomAb Ltd. as lead sponsor.

NCT NCT05824156
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05824156 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study of CM-101 in Patients With Non-Alcoholic Steatohepatitis (NASH)
Lead sponsor
ChemomAb Ltd.
Phase
Phase 2
Overall status
Completed
Start date
February 24, 2021
Completion date
August 25, 2022
Enrollment
23 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

nonalcoholic steatohepatitis